GREENLAND MINES LTD Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount
GREENLAND MINES LTD (GRML) had Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount of $0 as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount · last filed 2026-08-17
- 2026-06-30: Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |